Cite

HARVARD Citation

    Spicer, J. et al. (n.d.). Event-free survival (EFS) with neoadjuvant nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) versus chemo by surgical outcomes in resectable non-small cell lung cancer (NSCLC) from CheckMate 816. Lung cancer. pp. S26-S27. [Online].

Back to record